Akshat Jain: Read my view on the groundbreaking immunotherapy that has had revolutionary effect in treating the most common hematologic malignancy in children.

Akshat Jain, Medical Director, International Hematologist Oncologist & Stem Cell Transplant Specialist, Clinical Scientist & public health researcher, KOL Technocrat on Global Health, Hematology & Genomics, made the following post on LinkedIn:

“September is also childhood cancer awareness month.

Read my view on the groundbreaking immunotherapy that has had revolutionary effect in treating the most common hematologic malignancy in children.

Targeted therapy avoids unnecessary side effects of conventional chemotherapy(carpet bombing), and trains the immune system to search and destroy !

Currently not avaliable in lmics which is a shame.”

For details click here
Source: Akshat Jain / LinkedIn